glutathione and ovarian cancer Unbiased assessment of APR-246 responsive p53 mutants in Glutathione as a Prognostic Biomarker
Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer Frontiers Unveiling drug resistance pathways in high grade serous ovarian cancer(HGSOC): recent advances and future perspectives Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity Scientific Reports Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease Glutathione: Lights and Shadows in Cancer Patients PMC how does glutathione s transferase cause drug resistance in cancer cells Simplified scheme of action of the enzymes S transferases Chemotherapy Resistance of Ovarian Cancer
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





